Cargando…
Cyclophosphamide treatment for hypertension and renal injury in an experimental model of systemic lupus erythematosus
Cardiovascular disease is the major cause of mortality among patients with the autoimmune disorder systemic lupus erythematosus (SLE). Our laboratory previously reported that immunosuppression with mycophenolate mofetil, a common therapy in patients with SLE, attenuates the development of hypertensi...
Autores principales: | Wolf, Victoria L., Taylor, Erin B., Ryan, Michael J. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
John Wiley and Sons Inc.
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6533177/ https://www.ncbi.nlm.nih.gov/pubmed/31124322 http://dx.doi.org/10.14814/phy2.14059 |
Ejemplares similares
-
Curcumin attenuates autoimmunity and renal injury in an experimental model of systemic lupus erythematosus
por: Dent, Elena L., et al.
Publicado: (2020) -
Hypertension and endothelial dysfunction in the pristane model of systemic lupus erythematosus
por: McClung, Daniel M., et al.
Publicado: (2021) -
Systemic Lupus Erythematosus and Pulmonary Hypertension
por: Parperis, Konstantinos, et al.
Publicado: (2023) -
Asymptomatic Pulmonary Hypertension in Systemic Lupus Erythematosus
por: Kamel, Shereen R., et al.
Publicado: (2011) -
Two Cases of Refractory Thrombocytopenia in Systemic Lupus Erythematosus that Responded to Intravenous Low-Dose Cyclophosphamide
por: Park, Hee-Jin, et al.
Publicado: (2013)